Zobrazeno 1 - 10
of 72
pro vyhledávání: '"David, Polak"'
Autor:
Gourab Dey, Reut Sinai‐Turyansky, Evalyn Yakobovich, Emmanuelle Merquiol, Jure Loboda, Nikhila Sridharan, Yael Houri‐Haddad, David Polak, Simon Yona, Dusan Turk, Ori Wald, Galia Blum
Publikováno v:
Advanced Science, Vol 11, Iss 38, Pp n/a-n/a (2024)
Abstract Cathepsin‐K (CTSK) is an osteoclast‐secreted cysteine protease that efficiently cleaves extracellular matrices and promotes bone homeostasis and remodeling, making it an excellent therapeutic target. Detection of CTSK activity in complex
Externí odkaz:
https://doaj.org/article/55a9f6f7610d46bd811724ab06c48696
Publikováno v:
iScience, Vol 26, Iss 8, Pp 106430- (2023)
Summary: The study investigates the interplay of neutrophils and natural-killer cells (NK) in mediating osseoresorption during infection of molar-incisor-pattern-periodontitis (MIPP). Human neutrophils from periodontally healthy and MIPP patients wer
Externí odkaz:
https://doaj.org/article/1318d2267b8a44dda1d494362056c635
Autor:
Noy Pinto, Yehuda Klein, Eilon David, David Polak, Daniel Steinberg, Gilad Mizrahi, Yasmin Khoury, Yechezkel Barenholz, Stella Chaushu
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionAllografts are the most common bone grafts for repairing osseous defects. However, their use is associated with an increased risk for infections, donor disease transmission and osteointegration deficiency. Resolvin D1 (RvD1) is an endogen
Externí odkaz:
https://doaj.org/article/25f04266b60c4e5cb2648596a773822b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yehuda Klein, Offir Levin-Talmor, Jaime Garber Berkstein, Sharon Wald, Yaron Meirow, Avi Maimon, Avi Leibovich, Yechezkel Barenholz, David Polak, Stella Chaushu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The study aimed to investigate the role of RvD1 in acute and prolonged sterile inflammation and bone remodeling. A mouse model of sterile inflammation that involves bone resorption was used to examine endogenous RvD1 kinetics during inflammation. App
Externí odkaz:
https://doaj.org/article/6d7187d0b0394bacae0e27f6dcc6772e
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionMolar-incisor pattern periodontitis (MIPP) in the absence of significant local risk factors or systemic disease, is a rare, early onset periodontal disease phenotype, with 0.5% to 2.5% global prevalence. The condition is characterized by
Externí odkaz:
https://doaj.org/article/634b1208d38c4926b89d3694f812669a
Autor:
Aviv, Shmueli, Alin, Yaya, Neta, Lam, Yael, Haim, Lada, Zamsky, Avia, Fux Noy, Diana, Ram, Moti, Moskovitz, David, Polak
Publikováno v:
Clinical Oral Investigations; May2024, Vol. 28 Issue 5, p1-7, 7p
Publikováno v:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 134:449-456
To investigate the incorporation of the antifibrinolytic agent tranexamic acid (TA) during platelet-rich fibrin (PRF) formation to produce a robust fibrin agent with procoagulation properties.Blood from healthy volunteers was collected. Into 3 tubes,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72f8e307117807b47a89ddc8b29fef79
https://doi.org/10.1016/j.oooo.2022.03.006
https://doi.org/10.1016/j.oooo.2022.03.006
Publikováno v:
Journal of Oral Microbiology, Vol 11, Iss 1 (2019)
Objectives: The aim of the study was to characterize the immediate and delayed effects of non-coherent blue-light treatment on the composition and viability of an in vitro biofilm composed of anaerobic multispecies, as well as the mechanisms involved
Externí odkaz:
https://doaj.org/article/8decad70a90e4b2e93f6b5899741fafe
Autor:
Maria R. Jubran, Daniela Vilenski, Efrat Flashner-Abramson, Efraim Shnaider, Swetha Vasudevan, Ariel M. Rubinstein, Amichay Meirovitz, Shay Sharon, David Polak, Nataly Kravchenko-Balasha
Publikováno v:
Theranostics. 12:1204-1219
Therapeutic strategies for advanced head and neck squamous carcinoma (HNSCC) consist of multimodal treatment, including Epidermal Growth Factor Receptor (EGFR) inhibition, immune-checkpoint inhibition, and radio (chemo) therapy. Although over 90% of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad6bd5f8f5c527dec71183e2e8d6af7
https://doi.org/10.7150/thno.64347
https://doi.org/10.7150/thno.64347